Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
October 7th, 2021 |
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2023 |
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2024 |
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) |
National Institutes of Health |
April 5th, 2024 |
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
National Institutes of Health |
September 22nd, 2021 |
Health and Public Safety Workforce Resiliency Technical Assistance Center (HPSWRTAC) |
Health Resources and Services Administration |
September 22nd, 2021 |
Promoting Resilience and Mental Health Among Health Professional Workforce (PRMHW) |
Health Resources and Services Administration |
September 22nd, 2021 |
Health and Public Safety Workforce Resiliency Training Program |
Health Resources and Services Administration |
July 15th, 2022 |
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2024 |
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) |
National Institutes of Health |
October 20th, 2021 |
Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) |
National Institutes of Health |
January 18th, 2022 |
Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men in a Transformational Era |
Centers for Disease Control and Prevention ERA |
March 3rd, 2022 |
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
August 30th, 2021 |
Teaching Health Center Planning and Development --Technical Assistance |
Health Resources and Services Administration |
August 30th, 2021 |
Teaching Health Center Planning and Development Program |
Health Resources and Services Administration |
February 15th, 2022 |
Optimization and Standardization of Methods to Suppress Ixodes scapularis and Disrupt Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to Humans |
Centers for Disease Control and Prevention ERA |
October 20th, 2021 |
Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
October 11th, 2023 |
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) |
National Institutes of Health |
October 8th, 2021 |
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
March 3rd, 2022 |
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2021 |
Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
|
November 2nd, 2021 |
Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 18th, 2022 |
Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs |
Centers for Disease Control and Prevention ERA |
July 28th, 2021 |
Accessing Social Determinants of Health Data through Local Data Intermediaries Initiative |
Office of the Assistant Secretary for Health |
February 3rd, 2022 |
Family Planning Telehealth Infrastructure Enhancement and Expansion Grants |
Office of the Assistant Secretary for Health |
February 1st, 2022 |
Implementation Research on Telehealth Strategies to Support Retention in Care and Treatment among Antiretroviral Therapy (ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients |
Centers for Disease Control and Prevention ERA |
June 15th, 2023 |
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) |
National Institutes of Health |
January 11th, 2022 |
Title X Family Planning Services Grants |
Office of the Assistant Secretary for Health |
September 24th, 2021 |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
National Institutes of Health |
September 17th, 2021 |
Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional) |
National Institutes of Health |
October 6th, 2022 |
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 22nd, 2021 |
Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2023 |
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) |
National Institutes of Health |
October 30th, 2026 |
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) |
Agency for Health Care Research and Quality |
October 30th, 2026 |
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) |
Agency for Health Care Research and Quality |
May 26th, 2024 |
Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) |
Agency for Health Care Research and Quality |
September 7th, 2024 |
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) |
National Institutes of Health |
August 11th, 2022 |
Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) |
National Institutes of Health |
May 7th, 2023 |
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
December 1st, 2022 |
Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) |
National Institutes of Health |